Related Experiment Video
Updated: Sep 9, 2025

13:22
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
8.0K
Water-Based Pharmacophore Modeling in Kinase Inhibitor Design: A Case Study on Fyn and Lyn Protein Kinases.
Martin Ljubič1,2, Marija Sollner Dolenc2, Jure Borišek1
1National Institute of Chemistry, Hajdrihova 19, 1000, Ljubljana, Slovenia.
Journal of Chemical Information and Modeling
|September 1, 2025
Summary
Water-based pharmacophore modeling identifies novel kinase inhibitors by analyzing water dynamics in binding sites. This approach shows promise for drug discovery, particularly for under-explored targets like Fyn and Lyn kinases.
Area of Science:
- Computational chemistry
- Drug discovery
- Structural biology
Background:
- Water-based pharmacophore modeling is an emerging technique for inhibitor design.
- It utilizes explicit water molecule dynamics in ligand-free binding sites to create 3D pharmacophores for virtual screening.
- Fyn and Lyn protein kinases, part of the Src family, are relatively under-explored in anticancer drug discovery.
Purpose of the Study:
- To assess the potential of water-based pharmacophore modeling.
- To target the ATP binding sites of Fyn and Lyn protein kinases.
- To identify novel inhibitors for anticancer drug discovery.
Main Methods:
- Employed molecular dynamics simulations to generate and validate water-derived pharmacophores.
- Screened chemically diverse compound libraries using these pharmacophores.
- Conducted biochemical assays to test identified compounds.
- Utilized molecular docking and simulations for structural analysis of active compounds.
Main Results:
- Identified two active compounds: a flavonoid-like molecule (low-micromolar activity) and a synthetic compound.
- Key interactions, especially with the kinase hinge region and ATP pocket, were retained in bound states.
- Peripheral interactions with flexible regions (N-terminal lobe, activation loop) were less consistently captured.
Conclusions:
- Water-based pharmacophore modeling effectively captures conserved core interactions but may miss contacts influenced by protein flexibility.
- This ligand-independent strategy is promising for identifying novel chemotypes and exploring chemical space in kinases.
- Incorporating ligand information could enhance the modeling of flexible regions.
Related Concept Videos
Protein Kinases and Phosphatases
13.4K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Receptor Tyrosine Kinases
14.0K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.0K

